Related Experiment Videos
Virtual docking approaches to protein kinase B inhibition
Martino Forino1, Dawoon Jung, John B Easton
1The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
Journal of Medicinal Chemistry
|April 2, 2005
Summary
We explored computational methods to find inhibitors for Akt (protein kinase B). Experimental tests confirmed several compounds as low micromolar Akt1 inhibitors, validating these in silico strategies.
Area of Science:
- Biochemistry
- Computational Chemistry
- Drug Discovery
Background:
- Akt (protein kinase B) is a crucial target in various diseases.
- Identifying potent and selective Akt inhibitors remains a significant challenge in drug discovery.
Purpose of the Study:
- To evaluate the efficacy of different in silico approaches for identifying Akt inhibitors.
- To experimentally validate compounds predicted by computational methods.
Main Methods:
- Utilized in silico screening strategies including FlexX, GOLD, and CSCORE.
- Tested top-scoring compounds from a 50,000-compound library using fluorescence-based enzymatic and substrate phosphorylation assays.
- Employed GSK-3 as a substrate to assess Akt inhibition.
Main Results:
- Successfully identified low micromolar Akt1 inhibitors.
- Demonstrated both successes and failures of the employed in silico strategies.
- Validated the experimental utility of fluorescence-based and substrate phosphorylation assays.
Conclusions:
- In silico screening can effectively identify potential Akt inhibitors.
- Experimental validation is critical to confirm the efficacy of computationally identified compounds.
- The study provides insights into the strengths and limitations of various virtual screening tools for kinase inhibitor discovery.